Table 2. Experimental Conditions, Emulsion Formulations, and Droplet/Particle Sizes for Different Sample Runs.

		S1	S2	S3	S4	S5	S6	S7	S8	S9
nominal channel depth, DMC (μm)		5	4	2	4	4	4	4	4	4
dispersed phase composition (wt %)	SRL	1.32	1.32	1.32	1.32	1.64	1.76	1.80	1.84	2.25
	PLGA	2.68	2.68	2.68	2.68	2.34	2.24	2.20	2.16	2.25
	IPAc	72.00	72.00	72.00	72.00	72.00	72.00	72.00	72.00	71.63
	DCM	24.00	24.00	24.00	24.00	24.00	24.00	24.00	24.00	23.88
CP composition (wt %)	PVA	1.50	1.50	1.50	1.50	1.50	1.00	1.00	1.00	1.00
	Milli-Q water	98.50	98.50	98.50	98.50	98.50	99.00	99.00	99.00	99.00
drug loading (wt %)		33	33	33	33	42	44	45	46	50
total solids in the dispersed phase (wt %)		4	4	4	4	4	4	4	4	5
droplet production time		48 h	24 h	24 h	24 h	48 h	24 h	24 h	24 h	24 h
flowrate (mL/h)	dispersed phase	0.15	0.03	0.01	0.03	0.05	0.02	0.05	0.02
	CP	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
mean droplet size (μm)		23.5	13.8	5.2	13.8	13.8	13.8	13.6	13.8	13.5
CV of droplet sizes (%)		3.0	2.5	3.5	2.5	3.0	2.6	2.0	2.5	2.4
predicted particle size (μm)		7.0	4.1	1.5	4.1	4.2	4.2	4.3	4.3	4.5
mean particle size (μm)		8.5	3.8	1.8	4.2	4.0	4.2	4.2	4.2	4.3
CV of particle sizes (%)		4.5	5.2	6.0	5.2	4.1	4.3	5.1	4.8	4.6